Syngulon S.A.

https://www.syngulon.com

LinkedIn: https://www.linkedin.com/company/syngulon

Syngulon is a synthetic biology startup developing original technologies using bacteriocins. The team of scientists works in different academic partner laboratories including UCLouvain, ULB, ULiège in Belgium and UCL in the UK. R&D programs are supported by the Walloon Region of Belgium. Syngulon owns a collection (PARAGEN) of natural and synthetic bacteriocins. Syngulon has 8 patent application families related to bacteriocins including issued patents in EU, USA, India, Brasil and China. *

	Start	2017-02-16 existent
	Industry	synthetic biotechnology
	Industry 2	enzyme production technology
	Person	Hélin, Guy (Syngulon 201809 CEO + Co-Founder)
	Person 2	Gabant, Philippe (Syngulon 201810 CSO + Co-Founder)

	Region	Liège (Lüttich)
	Country	Belgium
	Street	15/1 Rue du Bois Saint Jean
	City	4102 Seraing
		Address record changed: 2020-12-02

Basic data	Employees	B: 11 to 50 (2022-04-27)

		* Document for »About Section«: Toulouse White Biotech (TWB). (4/27/22). "Press Release: TWB Expands Its Industrial Biotechnology Solutions by Partnering with Processium and Syngulon". London & Gosselies.

		Record changed: 2024-02-12